CNR1 and Huntington disease: A study evaluating mRNA levels of the cannabinoid receptors in Huntington’s disease R6/2 mouse model found that in the diseased model, CB1R and CB2R mRNA levels were normalized to the wildtype levels in the striatum and cortex of GAT211-treated mice [79].